<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03845244</url>
  </required_header>
  <id_info>
    <org_study_id>B-1809-492-006</org_study_id>
    <nct_id>NCT03845244</nct_id>
  </id_info>
  <brief_title>Weaning Protocol for High Flow Nasal Cannula Oxygen Therapy</brief_title>
  <acronym>SLOWH</acronym>
  <official_title>Simultaneous Reduction Versus Flow or Fraction of Inspired Oxygen Reduction First in Patients Ready to Wean From High Flow Nasal Cannula Oxygen Therapy: a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      High flow nasal cannula oxygen therapy has been widely used in critically ill patients.
      Despite effectiveness of high flow nasal cannula as a treatment, optimal methods to
      withdrawal high flow nasal cannula after recovery from preexisting conditions has not been
      investigated to date. In this study, we will evaluate the efficacy and safety of three
      different weaning methods in patients with high flow nasal cannula oxygen therapy.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Comparison of three weaning strategies: flow reduction first versus fraction of inspired
      oxygen (FiO2) first versus simultaneous reduction
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 24, 2019</start_date>
  <completion_date type="Anticipated">January 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Time to weaning success</measure>
    <time_frame>up to 2 weeks</time_frame>
    <description>The time to successfully remaining off high flow nasal cannula</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>weaning success or failure rate</measure>
    <time_frame>up to 2 weeks</time_frame>
    <description>Success or failure rate to wean off high flow nasal cannula</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>change of arterial partial pressure of oxygen, carbon dioxide, and pH</measure>
    <time_frame>up to 2 weeks</time_frame>
    <description>changes of arterial blood gas analyses</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>intolerance rate</measure>
    <time_frame>up to 2 weeks</time_frame>
    <description>intolerance to high flow nasal cannula</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>hospital length of stay</measure>
    <time_frame>during hospital admission, up to 12 weeks</time_frame>
    <description>hospital length of stay</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>In-hospital mortality</measure>
    <time_frame>during hospital admission, up to 12 weeks</time_frame>
    <description>all cause mortality</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>High Flow Nasal Cannula</condition>
  <condition>Respiratory Insufficiency</condition>
  <arm_group>
    <arm_group_label>Flow reduction first group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Flow reduction first -&gt; FiO2 reduction -&gt; conventional oxygen therapy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>FiO2 reduction first group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>FiO2 reduction first -&gt; flow reduction -&gt; conventional oxygen therapy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Simultaneous reduction group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Simultaneous (Flow and FiO2) reduction -&gt; conventional oxygen therapy</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Flow reduction first</intervention_name>
    <description>-10L/min q 1hr</description>
    <arm_group_label>Flow reduction first group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>FiO2 reduction first</intervention_name>
    <description>- 0.1 q 1hr</description>
    <arm_group_label>FiO2 reduction first group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Simultaneous (flow and FiO2) reduction</intervention_name>
    <description>-10L/min and -0.1 q 1hr</description>
    <arm_group_label>Simultaneous reduction group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  The patients applying high flow nasal cannula and satisfying the following weaning
             criteria.

               1. Patient who has recovered from the underlying condition

               2. No signs of respiratory distress like agitation, diaphoresis or anxiety

               3. Arterial pH ≥ 7.35, SpO2 &gt; 90% on FiO2 ≤ 0.5

               4. Respiratory rate ≤ 25/min, Heart rate ≤120/min, Systolic blood pressure ≥ 90mmHg

        Exclusion Criteria:

          -  Severe hypercapnia (pH &lt;7.25)

          -  Respiratory arrest requiring tracheal intubation

          -  Cardiac arrest, acute coronary syndrome or life threatening arrhythmias

          -  Failure of more than two organs

          -  Recent trauma or burns of the neck and face

          -  Non- cooperation

          -  Pregnancy

          -  Refusal of treatment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eun Sun Kim, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National University Bundang Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Eun Sun Kim, MD</last_name>
    <phone>+82-31-787-7086</phone>
    <email>apolio3700@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Seoul National University Bundang Hospital</name>
      <address>
        <city>Seongnam-si</city>
        <state>Gyeonggi-do</state>
        <zip>13620</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eun Sun Kim, MD</last_name>
      <phone>+82-31-787-7086</phone>
      <email>apolio3700@gmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>February 2019</verification_date>
  <study_first_submitted>February 11, 2019</study_first_submitted>
  <study_first_submitted_qc>February 15, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">February 19, 2019</study_first_posted>
  <last_update_submitted>February 15, 2019</last_update_submitted>
  <last_update_submitted_qc>February 15, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">February 19, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Bundang Hospital</investigator_affiliation>
    <investigator_full_name>Eun Sun Kim</investigator_full_name>
    <investigator_title>Associate professor</investigator_title>
  </responsible_party>
  <keyword>high flow nasal cannula</keyword>
  <keyword>weaning</keyword>
  <keyword>adult</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Insufficiency</mesh_term>
    <mesh_term>Pulmonary Valve Insufficiency</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

